FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kathleen Lamborn

Research Profile

Disorders

Procedures

Concepts & Ideas

Living Beings

Chemicals & Drugs

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Yan Li; Janine M Lupo; Soonmee Cha; Susan M Chang; Kathleen R Lamborn; Rupa Parvataneni; Sarah J Nelson
Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging.
Eudocia Q Lee; Victor A Levin; Frank Lieberman; Minesh Mehta; Michael D Prados; H Ian Robins; John J Wright; W K Alfred Yung; Lauren Abrey; Kenneth Aldape; Susan M Chang; Timothy F Cloughesy; Janet E Dancey; Lisa M DeAngelis; Jan Drappatz; Mark R Gilbert; John Kuhn; Kathleen R Lamborn; Patrick Y Wen
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.
Eudocia Q Lee; Frank S Lieberman; Renee M McGovern; Michael D Prados; Vinay K Puduvalli; Joel M Reid; H Ian Robins; Matthew M Ames; Susan M Chang; Timothy F Cloughesy; Serena Desideri; Jan Drappatz; Igor Espinoza-Delgado; Mark R Gilbert; John G Kuhn; Kathleen R Lamborn; Andrew B Lassman; Jihong Xu; Xiabu Ye; W K Alfred Yung; Patrick Y Wen
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kathleen Lamborn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yan Li; Janine M Lupo; Soonmee Cha; Susan M Chang; Kathleen R Lamborn; Rupa Parvataneni; Sarah J Nelson
Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging.
Neuro-oncology 2013;15(5):607-17.
2012: Eudocia Q Lee; Victor A Levin; Frank Lieberman; Minesh Mehta; Michael D Prados; H Ian Robins; John J Wright; W K Alfred Yung; Lauren Abrey; Kenneth Aldape; Susan M Chang; Timothy F Cloughesy; Janet E Dancey; Lisa M DeAngelis; Jan Drappatz; Mark R Gilbert; John Kuhn; Kathleen R Lamborn; Patrick Y Wen
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.
Neuro-oncology 2012;14(12):1511-8.
2012: Eudocia Q Lee; Frank S Lieberman; Renee M McGovern; Michael D Prados; Vinay K Puduvalli; Joel M Reid; H Ian Robins; Matthew M Ames; Susan M Chang; Timothy F Cloughesy; Serena Desideri; Jan Drappatz; Igor Espinoza-Delgado; Mark R Gilbert; John G Kuhn; Kathleen R Lamborn; Andrew B Lassman; Jihong Xu; Xiabu Ye; W K Alfred Yung; Patrick Y Wen
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(21):6032-9.
2012: Adam Schoenfeld; Tarik Tihan; Kathleen R Lamborn; Sabine Mueller; Melike Pekmezci; Anu Banerjee; Michael J Barnes; Mitchel S Berger; Susan Chang; Nalin Gupta; Daphne Haas-Kogan
The superiority of conservative resection and adjuvant radiation for craniopharyngiomas.
Journal of neuro-oncology 2012;108(1):133-9.
2012: Jorge A Caballero; Sandeep Denduluri; Kathleen R Lamborn; Lijun Ma; Jean L Nakamura; Penny K Sneed; Igor J Barani; Michael W McDermott
Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
International journal of radiation oncology, biology, physics 2012;83(1):303-9.
2012: Esin Ozturk-Isik; Andrea Pirzkall; Soonmee Cha; Susan M Chang; Kathleen R Lamborn; Sarah J Nelson
Spatial characteristics of newly diagnosed grade 3 glioma assessed by magnetic resonance metabolic and diffusion tensor imaging.
Translational oncology 2012;5(1):10-8.
2012: Aaron J Clark; Jennifer L Clarke; Kathleen R Lamborn; Michael W McDermott; Andrew T Parsa; Michael D Prados; Mitchel S Berger; Nicholas Butowski; Susan M Chang; Manish Aghi
Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.
Neurosurgery 2012;70(2):361-70.
2012: Arman Jahangiri; Sandeep Kunwar; Kathleen R Lamborn; Lewis Blevins; Manish Aghi
Factors associated with delay to pituitary adenoma diagnosis in patients with visual loss.
Journal of neurosurgery 2012;116(2):283-9.
2012: Mark R Gilbert; John Kuhn; Kathleen R Lamborn; Andrew B Lassman; Frank Lieberman; Minesh Mehta; Susan Chang; Timothy Cloughesy; Lisa M Deangelis; Patrick Y Wen; Michael Prados
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
Journal of neuro-oncology 2012;106(1):147-53.
2011: Nicholas Butowski; Susan M Chang; Jennifer Clarke; Bruno M Costa; Joseph F Costello; Maria Hristova-Kazmierski; Emily Hsieh; Kathleen R Lamborn; Steven J Nicol; Angelina Nicole; Rupa Parvataneni; Russell Pieper; Mei-Yin Polley; Rui M Reis; Patricia K Sneed; Donald E Thornton; Scott Vandenberg; Michael D Prados
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.
Neuro-oncology 2011;13(12):1331-8.
2011: Phioanh Leia Nghiemphu; Michael D Prados; H Ian Robins; Alejandro Torres-Trejo; Patrick Y Wen; Lauren E Abrey; Susan M Chang; Timothy F Cloughesy; Lisa M DeAngelis; Alexis Demopoulos; Jan Drappatz; Howard A Fine; Karen Fink; Santosh Kesari; Kathleen R Lamborn; Andrew B Lassman; Frank S Lieberman; Mark G Malkin; Minesh Mehta
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.
International journal of radiation oncology, biology, physics 2011;81(5):1422-7.
2011: Mei-Yin C Polley; Nicholas Butowski; Susan M Chang; Jennifer L Clarke; Kathleen R Lamborn; Michael Prados
Conditional probability of survival in patients with newly diagnosed glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(31):4175-80.
2011: Matthew B Potts; Lewis S Blevins; Arman Jahangiri; Sandeep Kunwar; Kathleen R Lamborn; Manish Aghi
Suprasellar Rathke cleft cysts: clinical presentation and treatment outcomes.
Neurosurgery 2011;69(5):1058-68; discussion 1068-7.
2011: Jennifer L Clarke; Michele M Ennis; Lauren Abrey; Kenneth Aldape; Susan M Chang; Timothy F Cloughesy; Lisa M Deangelis; Howard A Fine; Mark R Gilbert; John Kuhn; Kathleen R Lamborn; Frank S Lieberman; Minesh Mehta; Michael D Prados; H Ian Robins; Patrick Y Wen; W K Alfred Yung
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Neuro-oncology 2011;13(10):1118-24.
2011: John F de Groot; Lisa De Angelis; Mark R Gilbert; Edward F Jackson; Kathleen R Lamborn; Andrew B Lassman; Frank S Lieberman; Minesh Mehta; Michael D Prados; H Ian Robins; Kenneth Aldape; Susan M Chang; Alice Chen; Timothy F Cloughesy; Jun Yao; W K Alfred Yung; Patrick Y Wen
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2689-95.
2011: Fabio M Iwamoto; Kathleen R Lamborn; John Kuhn; Patrick Y Wen; Mark R Gilbert; Susan M Chang; Frank S Lieberman; Michael D Prados; W K Alfred Yung; Howard A Fine
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.
Neuro-oncology 2011;13(5):509-16.
2011: David A Reardon; Evanthia Galanis; John F DeGroot; Timothy F Cloughesy; Jeffrey S Wefel; Kathleen R Lamborn; Andrew B Lassman; Mark R Gilbert; John H Sampson; Wolfgang Wick; Marc C Chamberlain; David R Macdonald; Minesh Mehta; Michael A Vogelbaum; Susan M Chang; Martin J van den Bent; Patrick Y Wen
Clinical trial end points for high-grade glioma: the evolving landscape.
Neuro-oncology 2011;13(3):353-61.
2010: Fabio M Iwamoto; Kathleen R Lamborn; H Ian Robins; Minesh Mehta; Susan M Chang; Nicholas A Butowski; Lisa De Angelis; Lauren E Abrey; Wei-Ting Zhang; Michael D Prados; Howard A Fine
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).
Neuro-oncology 2010;12(8):855-61.
2010: Nicholas Butowski; Susan M Chang; Kathleen R Lamborn; Mei Yin Polley; R Parvataneni; Maria Hristova-Kazmierski; Luna Musib; Steven J Nicol; Donald E Thornton; Michael D Prados
Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study.
Neuro-oncology 2010;12(6):608-13.
2010: Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(11):1963-72.
2010: Mei-Yin C Polley; Kathleen R Lamborn; Susan M Chang; Nicholas Butowski; Jennifer L Clarke; Michael Prados
Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.
Neuro-oncology 2010;12(3):274-82.
2010: Sean M McBride; Daniel A Perez; Mei-Yin Polley; Scott R Vandenberg; Justin S Smith; Shichun Zheng; Kathleen R Lamborn; John K Wiencke; Susan M Chang; Michael D Prados; Mitchel S Berger; David Stokoe; Daphne A Haas-Kogan
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival.
Journal of neuro-oncology 2010;97(1):33-40.
2010: Wenting Wu; Kathleen R Lamborn; Jan C Buckner; Paul J Novotny; Susan M Chang; Judith R O'Fallon; Kurt A Jaeckle; Michael D Prados
Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma.
Neuro-oncology 2010;12(2):164-72.
2010: Jeffrey J Raizer; Lauren E Abrey; Andrew B Lassman; Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Kenneth A Aldape; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank Lieberman; Timothy F Cloughesy; H Ian Robins; Janet Dancey; Michael D Prados
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.
Neuro-oncology 2010;12(1):95-103.
2010: Jeffrey J Raizer; Lauren E Abrey; Andrew B Lassman; Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Kenneth Aldape; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank Lieberman; Timothy F Cloughesy; H Ian Robins; Janet Dancey; Michael D Prados
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas.
Neuro-oncology 2010;12(1):87-94.
2010: Andrew D Norden; Jeffrey J Raizer; Lauren E Abrey; Kathleen R Lamborn; Andrew B Lassman; Susan M Chang; W K Alfred Yung; Mark R Gilbert; Howard A Fine; Minesh Mehta; Lisa De Angelis; Timothy F Cloughesy; H Ian Robins; Kenneth Aldape; Janet Dancey; Michael D Prados; Frank Lieberman; Patrick Y Wen
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Journal of neuro-oncology 2010;96(2):211-7.
2009: Wei Bian; Inas S Khayal; Janine M Lupo; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson
Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.
Translational oncology 2009;2(4):271-80.
2009: Patrick Y Wen; W K Alfred Yung; Kathleen R Lamborn; Andrew D Norden; Timothy F Cloughesy; Lauren E Abrey; Howard A Fine; Susan M Chang; H Ian Robins; Karen Fink; Lisa De Angelis; Minesh Mehta; Emmanuelle di Tomaso; Jan Drappatz; Santosh kesari; Keith L Ligon; Ken Aldape; Rakesh K Jain; Charles D Stiles; Merrill J Egorin; Michael D Prados
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Neuro-oncology 2009;11(6):853-60.
2009: Andrea Pirzkall; Colleen McGue; Suja Saraswathy; Soonmee Cha; Raymond Liu; Scott R Vandenberg; Kathleen R Lamborn; Mitchel S Berger; Susan M Chang; Sarah J Nelson
Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.
Neuro-oncology 2009;11(6):842-52.
2009: Kelly Fishman; Jennifer Baure; Yani Zou; Ting-Ting Huang; Marta Andres-Mach; Radoslaw Rola; Tatiana Suarez; Munjal Acharya; Charles L Limoli; Kathleen R Lamborn; John R Fike
Radiation-induced reductions in neurogenesis are ameliorated in mice deficient in CuZnSOD or MnSOD.
Free radical biology & medicine 2009;47(10):1459-67.
2009: Daniel A Lim; Phiroz Tarapore; Edward Chang; Marlene Burt; Lenna Chakalian; Nicholas M Barbaro; Susan Chang; Kathleen R Lamborn; Michael W McDermott
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Journal of neuro-oncology 2009;93(3):349-54.
2009: Tene A Cage; Kathleen R Lamborn; Marcus L Ware; Anna Frankfurt; Lenna Chakalian; Mitchell S Berger; Michael W McDermott
Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas.
Journal of neuro-oncology 2009;93(1):151-6.
2009: Inas S Khayal; Tracy R McKnight; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson
Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas.
NMR in biomedicine 2009;22(4):449-55.
2009: Nicholas M Barbaro; Mark Quigg; Donna K Broshek; Mariann M Ward; Kathleen R Lamborn; Kenneth D Laxer; David A Larson; William Dillon; Lynn Verhey; Paul Garcia; Ladislau Steiner; Christi Heck; Douglas Kondziolka; Robert Beach; Charles William Olivero; Thomas C Witt; Vicenta Salanova; Robert Goodman
A multicenter, prospective pilot study of gamma knife radiosurgery for mesial temporal lobe epilepsy: seizure response, adverse events, and verbal memory.
Annals of neurology 2009;65(2):167-75.
2009: Michael D Prados; Susan M Chang; Nicholas Butowski; Rebecca DeBoer; Rupa Parvataneni; Hannah Carliner; Paul Kabuubi; Jennifer Ayers-Ringler; Jane Rabbitt; Margaretta Page; Anne Fedoroff; Penny K Sneed; Mitchel S Berger; Michael W McDermott; Andrew T Parsa; Scott Vandenberg; C David James; Kathleen R Lamborn; David Stokoe; Daphne A Haas-Kogan
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):579-84.
2009: Forrest W Crawford; Inas S Khayal; Colleen McGue; Suja Saraswathy; Andrea Pirzkall; Soonmee Cha; Kathleen R Lamborn; Susan M Chang; Mitchel S Berger; Sarah J Nelson
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.
Journal of neuro-oncology 2009;91(3):337-51.
2009: Raymond Liu; Karla Solheim; Mei-Yin Polley; Kathleen R Lamborn; Margaretta Page; Anne Fedoroff; Jane Rabbitt; Nicholas Butowski; Michael Prados; Susan M Chang
Quality of life in low-grade glioma patients receiving temozolomide.
Neuro-oncology 2009;11(1):59-68.
2009: Nicholas Butowski; Kathleen R Lamborn; Bee L Lee; Michael D Prados; Timothy F Cloughesy; Lisa De Angelis; Lauren E Abrey; Karen Fink; Frank S Lieberman; Minesh Mehta; H Ian Robins; Larry Junck; Andres M Salazar; Susan M Chang
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.
Journal of neuro-oncology 2009;91(2):183-9.
2009: Suja Saraswathy; Forrest W Crawford; Kathleen R Lamborn; Andrea Pirzkall; Susan Chang; Soonmee Cha; Sarah J Nelson
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.
Journal of neuro-oncology 2009;91(1):69-81.
2009: Nicholas Butowski; Susan M Chang; Larry Junck; Lisa De Angelis; Lauren E Abrey; Karen Fink; Timothy F Cloughesy; Kathleen R Lamborn; Andres M Salazar; Michael D Prados
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).
Journal of neuro-oncology 2009;91(2):175-82.
2009: Ralph Philip Ermoian; Tania Kaprealian; Kathleen R Lamborn; Xiaodong Yang; Nannette Jelluma; Nils D Arvold; Ruth Zeidman; Mitchel S Berger; David Stokoe; Daphne A Haas-Kogan
Signal transduction molecules in gliomas of all grades.
Journal of neuro-oncology 2009;91(1):19-26.
2008: Daniel W Golden; Kathleen R Lamborn; Michael W McDermott; Sandeep Kunwar; William M Wara; Jean L Nakamura; Penny K Sneed
Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Journal of neurosurgery 2008;109 Suppl():77-86.
2008: Sean M McBride; Sally M Daganzo; Anuradha Banerjee; Nalin Gupta; Kathleen R Lamborn; Michael D Prados; Mitchel S Berger; William M Wara; Daphne A Haas-Kogan
Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
International journal of radiation oncology, biology, physics 2008;72(5):1319-23.
2008: Edward F Chang; Justin S Smith; Susan M Chang; Kathleen R Lamborn; Michael D Prados; Nicholas Butowski; Nicholas M Barbaro; Andrew T Parsa; Mitchel S Berger; Michael M McDermott
Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.
Journal of neurosurgery 2008;109(5):817-24.
2008: Susan M Chang; Kathleen R Lamborn; John Kuhn; W K Alfred Yung; Mark R Gilbert; Patrick Y Wen; Howard A Fine; Minesh Mehta; Lisa De Angelis; Frank S Lieberman; Timothy F Cloughesy; H Ian Robins; Lauren E Abrey; Michael D Prados
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
Neuro-oncology 2008;10(4):631-42.
2008: Radoslaw Rola; Kelly Fishman; Jennifer Baure; Susanna Rosi; Kathleen R Lamborn; Andre Obenaus; Gregory A Nelson; John R Fike
Hippocampal neurogenesis and neuroinflammation after cranial irradiation with (56)Fe particles.
Radiation research 2008;169(6):626-32.
2008: Inas S Khayal; Forrest W Crawford; Suja Saraswathy; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Tracy R McKnight; Sarah J Nelson
Relationship between choline and apparent diffusion coefficient in patients with gliomas.
Journal of magnetic resonance imaging : JMRI 2008;27(4):718-25.
2008: Edward F Chang; Gabriel Zada; Sang Kim; Kathleen R Lamborn; A QUINONES-HINOJOSA; J Blake Tyrrell; Charles B Wilson; Sandeep Kunwar
Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas.
Journal of neurosurgery 2008;108(4):736-45.
2008: Kathleen R Lamborn; W K Alfred Yung; Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Lisa De Angelis; H Ian Robins; Frank S Lieberman; Howard A Fine; Karen L Fink; Larry Junck; Lauren E Abrey; Mark R Gilbert; Minesh Mehta; John Kuhn; Kenneth Aldape; Janelle Hibberts; Pamela M Peterson; Michael D Prados
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
Neuro-oncology 2008;10(2):162-70.
2008: Rintaro Hashizume; Tomoko Ozawa; Sergei Gryaznov; Andrew W Bollen; Kathleen R Lamborn; William H Frey; Dennis F Deen
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.
Neuro-oncology 2008;10(2):112-20.
2008: Justin S Smith; Edward F Chang; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Soonmee Cha; Tarik Tihan; Scott Vandenberg; Michael W McDermott; Mitchel S Berger
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1338-45.
2008: Efstathios Papavassiliou; Geoff Rau; Susan Heath; Aviva Abosch; Nicholas M Barbaro; Paul S Larson; Kathleen R Lamborn; Philip A Starr
Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome.
Neurosurgery 2008;62 Suppl 2():884-94.
2008: Edward F Chang; Matthew B Potts; G Evren Keles; Kathleen R Lamborn; Susan M Chang; Nicholas M Barbaro; Mitchel S Berger
Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
Journal of neurosurgery 2008;108(2):227-35.
2007: John Kuhn; Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Harry S Greenberg; David Schiff; Charles Conrad; Karen L Fink; H Ian Robins; Minesh Mehta; Lisa De Angelis; Jeffrey J Raizer; Kenneth Hess; Kathleen R Lamborn; Janet Dancey; Michael D Prados
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7401-6.
2007: Monica E Loghin; Michael D Prados; Patrick Y Wen; Larry Junck; Frank S Lieberman; Howard A Fine; Karen L Fink; Minesh Metha; John Kuhn; Kathleen R Lamborn; Susan M Chang; Timothy F Cloughesy; Lisa De Angelis; Ian H Robins; Kenneth Aldape; W K Alfred Yung
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):7133-8.
2007: Allen M Chen; Susan Chang; Jean Pouliot; Penny K Sneed; Michael D Prados; Kathleen R Lamborn; Mary Malec; Michael W McDermott; Mitchel S Berger; David A Larson
Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
International journal of radiation oncology, biology, physics 2007;69(3):825-30.
2007: Nicholas Butowski; Kathleen R Lamborn; Mitchel S Berger; Michael D Prados; Susan M Chang
Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme.
Journal of neuro-oncology 2007;85(1):87-94.
2007: Orazio Schillaci; Gerald L DeNardo; Sally J DeNardo; Desiree S Goldstein; Linda A Kroger; Robert T O'Donnell; Kathleen R Lamborn
Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.
Cancer biotherapy & radiopharmaceuticals 2007;22(4):521-30.
2007: John K Wiencke; Shichun Zheng; Nannette Jelluma; Tarik Tihan; Scott R Vandenberg; Tanja Tamgüney; Rachel Baumber; Ramon Parsons; Kathleen R Lamborn; Mitchel S Berger; Margaret Wrensch; Daphne A Haas-Kogan; David Stokoe
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.
Neuro-oncology 2007;9(3):271-9.
2007: Tracy R McKnight; Kathleen R Lamborn; Tonya D Love; Mitchel S Berger; Susan Chang; William P Dillon; Andrew Bollen; Sarah J Nelson
Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas.
Journal of neurosurgery 2007;106(4):660-6.
2007: Justin S Smith; Ian F Parney; Kathleen R Lamborn; Michael W McDermott; Penny K Sneed; Susan M Chang
Treatment for posterior fossa dissemination of primary supratentorial glioma.
Journal of neurosurgery 2007;106(4):567-74.
2007: Jennifer K Chen; Lily J Hu; Dongfang Wang; Kathleen R Lamborn; Dennis F Deen
Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.
International journal of radiation oncology, biology, physics 2007;67(5):1538-47.
2007: Michal Entin-Meer; Xiaodong Yang; Scott R Vandenberg; Kathleen R Lamborn; Abraham Nudelman; Ada Rephaeli; Daphne A Haas-Kogan
In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.
Neuro-oncology 2007;9(2):82-8.
2007: Myoung-Seo Koo; Tomoko Ozawa; Raquel A Santos; Kathleen R Lamborn; Andrew W Bollen; Dennis F Deen; Stephen B Kahl
Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins.
Journal of medicinal chemistry 2007;50(4):820-7.
2007: Morris D Groves; Vinay K Puduvalli; Susan M Chang; Charles A Conrad; Mark R Gilbert; Ivo W Tremont-Lukats; Ta-Jen Liu; Pamela Peterson; David Schiff; Timothy F Cloughesy; Patrick Y Wen; Harry S Greenberg; Lauren E Abrey; Lisa De Angelis; Kenneth R Hess; Kathleen R Lamborn; Michael D Prados; W K Alfred Yung
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
Journal of neuro-oncology 2007;81(3):271-7.
2007: Heon Yoo; Gilson Baia; Justin S Smith; Michael W McDermott; Andrew W Bollen; Scott R Vandenberg; Kathleen R Lamborn; Anita Lal
Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):68-75.
2006: Ignacio Azinovic; Gerald L DeNardo; Kathleen R Lamborn; Gary R Mirick; Desiree Goldstein; Bonnie M Bradt; Sally J DeNardo
Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies.
Cancer immunology, immunotherapy : CII 2006;55(12):1451-8.
2006: Tomoko Ozawa; Bruce A Faddegon; Lily J Hu; Andrew W Bollen; Kathleen R Lamborn; Dennis F Deen
Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures.
International journal of radiation oncology, biology, physics 2006;66(1):263-70.
2006: Timothy F Cloughesy; Patrick Y Wen; H Ian Robins; Susan M Chang; Morris D Groves; Karen L Fink; Larry Junck; David Schiff; Lauren E Abrey; Mark R Gilbert; Frank S Lieberman; John Kuhn; Lisa De Angelis; Minesh Mehta; Jeffrey J Raizer; W K Alfred Yung; Kenneth Aldape; John Wright; Kathleen R Lamborn; Michael D Prados
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3651-6.
2006: G Evren Keles; Edward F Chang; Kathleen R Lamborn; Tarik Tihan; Chih-Ju Chang; Susan M Chang; Mitchel S Berger
Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma.
Journal of neurosurgery 2006;105(1):34-40.
2006: Margaret Wrensch; John K Wiencke; Joseph L Wiemels; Rei Miike; Joe Patoka; Michelle Moghadassi; Alex McMillan; Karl T Kelsey; Kenneth Aldape; Kathleen R Lamborn; Andrew T Parsa; Jennette D Sison; Michael D Prados
Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival.
Cancer research 2006;66(8):4531-41.
2006: Michael D Prados; Kathleen R Lamborn; W K Alfred Yung; Kurt A Jaeckle; H Ian Robins; Minesh Mehta; Howard A Fine; Patrick Y Wen; Timothy F Cloughesy; Susan Chang; M Kelly Nicholas; David Schiff; Harry S Greenberg; Larry Junck; Karen Fink; Kenneth Hess; John Kuhn
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Neuro-oncology 2006;8(2):189-93.
2006: Kavita K Mishra; Dev R Puri; Brian T Missett; Kathleen R Lamborn; Michael D Prados; Mitchel S Berger; Anuradha Banerjee; Nalin Gupta; William M Wara; Daphne A Haas-Kogan
The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.
Neuro-oncology 2006;8(2):166-74.
2006: Tarik Tihan; Justine Barletta; Ian F Parney; Kathleen R Lamborn; Penny K Sneed; Susan Chang
Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions?
Human pathology 2006;37(3):272-82.
2006: Michael D Prados; Kathleen R Lamborn; Susan Chang; Eric Burton; Nicholas Butowski; Mary Malec; Ami Kapadia; Jane Rabbitt; Margaretta S Page; Ann Fedoroff; Dong Xie; Sean K Kelley
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma.
Neuro-oncology 2006;8(1):67-78.
2006: Margaret Wrensch; Terri Rice; Rei Miike; Alex McMillan; Kathleen R Lamborn; Kenneth Aldape; Michael D Prados
Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.
Neuro-oncology 2006;8(1):12-26.
2006: Anjan Misra; Malgorzata Pellarin; Lily Hu; Sandeep Kunwar; Mark Perhouse; Kathleen R Lamborn; Dennis F Deen; Burt Feuerstein
Chromosome transfer experiments link regions on chromosome 7 to radiation resistance in human glioblastoma multiforme.
Genes, chromosomes & cancer 2006;45(1):20-30.
2005: Laird A Miers; Sally J DeNardo; Kathleen R Lamborn; Gerald L DeNardo
Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograft.
Cancer biotherapy & radiopharmaceuticals 2005;20(6):614-9.
2005: Tomoko Ozawa; Gavin W Britz; David H Kinder; Alexander M Spence; Scott R Vandenberg; Kathleen R Lamborn; Dennis F Deen; Mitchel S Berger
Bromophenol blue staining of tumors in a rat glioma model.
Neurosurgery 2005;57(5):1041-7; discussion 1041-7.
2005: Andrew B Lassman; Michael R Rossi; Jeffrey J Raizer; Jeffrey R Razier; Lauren E Abrey; Frank S Lieberman; Chelsea N Grefe; Kathleen R Lamborn; William Pao; Alan H Shih; John Kuhn; Richard Wilson; Norma J Nowak; John Kenneth Cowell; Lisa De Angelis; Patrick Y Wen; Mark R Gilbert; Susan Chang; W A Yung; Michael Prados; Eric C Holland
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7841-50.
2005: Ying Lu; Hua Jin; Kathleen R Lamborn
A design of phase II cancer trials using total and complete response endpoints.
Statistics in medicine 2005;24(20):3155-70.
2005: Susan M Chang; Sharon L Reynolds; Nicholas Butowski; Kathleen R Lamborn; Jan C Buckner; Richard S. Kaplan; Darell D Bigner
GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.
Neuro-oncology 2005;7(4):425-34.
2005: Laird A Miers; Kathleen R Lamborn; Aina Yuan; Carol M Richman; Arutselvan Natarajan; Sally J DeNardo; Gerald L DeNardo
Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7158s-7163s.
2005: Daphne A Haas-Kogan; Michael D Prados; Kathleen R Lamborn; Tarik Tihan; Mitchel S Berger; David Stokoe
Biomarkers to predict response to epidermal growth factor receptor inhibitors.
Cell cycle (Georgetown, Tex.) 2005;4(10):1369-72.
2005: Timothy F Cloughesy; John Kuhn; H Ian Robins; Lauren E Abrey; Patrick Y Wen; Karen Fink; Frank S Lieberman; Minesh Mehta; Susan Chang; Alfred Yung; Lisa De Angelis; David Schiff; Larry Junck; Morris Groves; Steve Paquette; John Wright; Kathleen R Lamborn; Said M Sebti; Michael Prados
Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6647-56.
2005: Tomoko Ozawa; Javed Afzal; Kathleen R Lamborn; Andrew W Bollen; William F Bauer; Myoung-Seo Koo; Stephen B Kahl; Dennis F Deen
Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
International journal of radiation oncology, biology, physics 2005;63(1):247-52.
2005: Carol M Richman; Sally J DeNardo; Robert T O'Donnell; Aina Yuan; Sui Shen; Desiree S Goldstein; Joseph M Tuscano; Ted Wun; Helen K Chew; Primo Lara; David L Kukis; Arutselvan Natarajan; Claude F Meares; Kathleen R Lamborn; Gerald L DeNardo
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5920-7.
2005: Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Harry S Greenberg; David Schiff; Charles Conrad; Karen Fink; H Ian Robins; Lisa De Angelis; Jeffrey J Raizer; Kenneth Hess; Kenneth Aldape; Kathleen R Lamborn; John Kuhn; Janet Dancey; Michael D Prados
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.
Investigational new drugs 2005;23(4):357-61.
2005: Daniel R Gomez; Brian T Missett; William M Wara; Kathleen R Lamborn; Michael D Prados; Susan Chang; Mitchel S Berger; Daphne A Haas-Kogan
High failure rate in spinal ependymomas with long-term follow-up.
Neuro-oncology 2005;7(3):254-9.
2005: Daphne A Haas-Kogan; Michael D Prados; Tarik Tihan; David A Eberhard; Nannette Jelluma; Nils D Arvold; Rachel Baumber; Kathleen R Lamborn; Ami Kapadia; Mary Malec; Mitchel S Berger; David Stokoe
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
Journal of the National Cancer Institute 2005;97(12):880-7.
2005: Jennifer K Chen; Lily J Hu; Jingli Wang; Kathleen R Lamborn; Eileen L Kong; Dennis F Deen
Hypoxia-induced BAX overexpression and radiation killing of hypoxic glioblastoma cells.
Radiation research 2005;163(6):644-53.
2005: A QUINONES-HINOJOSA; Russ Lyon; Gabriel Zada; Kathleen R Lamborn; Nalin Gupta; Andrew T Parsa; Michael W McDermott; Philip R Weinstein
Changes in transcranial motor evoked potentials during intramedullary spinal cord tumor resection correlate with postoperative motor function.
Neurosurgery 2005;56(5):982-93; discussion 982-93.
2005: Tomoko Ozawa; Jethro L Hu; Lily J Hu; Eileen L Kong; Andrew W Bollen; Kathleen R Lamborn; Dennis F Deen
Functionality of hypoxia-induced BAX expression in a human glioblastoma xenograft model.
Cancer gene therapy 2005;12(5):449-55.
2005: Yu Liang; Maximilian Diehn; Nathan Watson; Andrew W Bollen; Kenneth Aldape; M Kelly Nicholas; Kathleen R Lamborn; Mitchel S Berger; David Botstein; Patrick O Brown; Mark Israel
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(16):5814-9.
2005: Anjan Misra; Malgorzata Pellarin; Janice Nigro; Ivan Smirnov; Dan Moore; Kathleen R Lamborn; Daniel Pinkel; Donna G Albertson; Burt Feuerstein
Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2907-18.
2005: Andrew T Parsa; Scott Wachhorst; Kathleen R Lamborn; Michael D Prados; Michael W McDermott; Mitchel S Berger; Susan M Chang
Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults.
Journal of neurosurgery 2005;102(4):622-8.
2005: Nicholas Butowski; Michael D Prados; Kathleen R Lamborn; David A Larson; Penny K Sneed; William M Wara; Mary Malec; Jane Rabbitt; Margaretta Page; Susan M Chang
A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma.
International journal of radiation oncology, biology, physics 2005;61(5):1454-9.
2005: Dongfang Wang; Hangjun Ruan; Lily Hu; Kathleen R Lamborn; Eileen L Kong; Alnawaz Rehemtulla; Dennis F Deen
Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
Cancer gene therapy 2005;12(3):276-83.
2004: Gary Hammer; J Blake Tyrrell; Kathleen R Lamborn; Carol B Applebury; Elizabeth T Hannegan; Scott Bell; Riva Rahl; Amy Lu; Charles B Wilson
Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
The Journal of clinical endocrinology and metabolism 2004;89(12):6348-57.
2004: Susan M Chang; Kathleen R Lamborn; Mary Malec; David Larson; William W Wara; Penny K Sneed; Jane Rabbitt; Margaretta Page; M Kelly Nicholas; Michael D Prados
Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.
International journal of radiation oncology, biology, physics 2004;60(2):353-7.
2004: Tomoko Ozawa; Raquel A Santos; Kathleen R Lamborn; William F Bauer; Myoung-Seo Koo; Stephen B Kahl; Dennis F Deen
In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts.
Molecular pharmaceutics 2004;1(5):368-74.
2004: Kathleen R Lamborn; Susan M Chang; Michael D Prados
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.
Neuro-oncology 2004;6(3):227-35.
2004: Tomoko Ozawa; Sergei Gryaznov; Lily J Hu; Krisztina Pongracz; Raquel A Santos; Andrew W Bollen; Kathleen R Lamborn; Dennis F Deen
Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
Neuro-oncology 2004;6(3):218-26.
2004: Efstathios Papavassiliou; Geoff Rau; Susan Heath; Aviva Abosch; Nicholas M Barbaro; Paul S Larson; Kathleen R Lamborn; Philip A Starr
Thalamic deep brain stimulation for essential tremor: relation of lead location to outcome.
Neurosurgery 2004;54(5):1120-29; discussion 1129-30.
2004: David A Larson; Jeffrey M Suplica; Susan M Chang; Kathleen R Lamborn; Michael W McDermott; Penny K Sneed; Michael D Prados; William M Wara; M Kelly Nicholas; Mitchel S Berger
Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.
Neuro-oncology 2004;6(2):119-26.
2004: G Evren Keles; David A Lundin; Kathleen R Lamborn; Edward F Chang; George A Ojemann; Mitchel S Berger
Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients.
Journal of neurosurgery 2004;100(3):369-75.
2004: Susan M Chang; Philip Theodosopoulos; Kathleen R Lamborn; Mary Malec; Jane Rabbitt; Margaretta Page; Michael D Prados
Temozolomide in the treatment of recurrent malignant glioma.
Cancer 2004;100(3):605-11.
2004: G Evren Keles; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Mitchel S Berger
Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy.
Journal of neurosurgery 2004;100(1):41-6.
2003: Kurtis I Auguste; A QUINONES-HINOJOSA; Chirag A Gadkary; Gabriel Zada; Kathleen R Lamborn; Mitchel S Berger
Incidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg.
Journal of neurosurgery 2003;99(4):680-4.
2003: Gerald L DeNardo; Gary R Mirick; Linda A Kroger; Bonnie M Bradt; Kathleen R Lamborn; Sally J DeNardo
Characterization of human IgG antimouse antibody in patients with B-cell malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):4013S-21S.
2003: Sally J DeNardo; Gerald L DeNardo; Aina Yuan; Carol M Richman; Robert T O'Donnell; Primo Lara; David L Kukis; Arutselvan Natarajan; Kathleen R Lamborn; Frederik Jacobs; Christine L Hartmann Siantar
Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3938S-44S.
2003: Gerald L DeNardo; Sally J DeNardo; James J Peterson; Laird A Miers; Kit S Lam; Christine Hartmann Siantar; Kathleen R Lamborn
Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3865S-72S.
2003: Sally J DeNardo; Zhengsheng Yao; Kit S Lam; Aimin Song; Patricia A Burke; Gary R Mirick; Kathleen R Lamborn; Robert T O'Donnell; Gerald L DeNardo
Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3854S-64S.
2003: Michelle D Winthrop; Sally J DeNardo; Huguette Albrecht; Gary R Mirick; Linda A Kroger; Kathleen R Lamborn; Ceslovas Venclovas; Michael E Colvin; Patricia A Burke; Gerald L DeNardo
Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3845S-53S.
2003: G Evren Keles; Kathleen R Lamborn; Mitchel S Berger
Coregistration accuracy and detection of brain shift using intraoperative sononavigation during resection of hemispheric tumors.
Neurosurgery 2003;53(3):556-62; discussion 562-4.
2003: G Edward Vates; Susan Chang; Kathleen R Lamborn; Michael Prados; Mitchel S Berger
Gliomatosis cerebri: a review of 22 cases.
Neurosurgery 2003;53(2):261-71; discussion 271.
2003: Jingli Wang; Jack Klem; Jan B Wyrick; Tomoko Ozawa; Erin Cunningham; Jay Golinveaux; Max J Allen; Kathleen R Lamborn; Dennis F Deen
Detection of hypoxia in human brain tumor xenografts using a modified comet assay.
Neoplasia (New York, N.Y.) 2003;5(4):288-96.
2003: Meic H Schmidt; Mitchel S Berger; Kathleen R Lamborn; Kenneth Aldape; Michael W McDermott; Michael D Prados; Susan M Chang
Repeated operations for infiltrative low-grade gliomas without intervening therapy.
Journal of neurosurgery 2003;98(6):1165-9.
2003: Daphne A Haas-Kogan; Brian T Missett; William M Wara; Sarah S Donaldson; Kathleen R Lamborn; Michael D Prados; Paul G Fisher; Stephen L Huhn; Benjamin M Fisch; Mitchel S Berger; Quynh-Thu Le
Radiation therapy for intracranial germ cell tumors.
International journal of radiation oncology, biology, physics 2003;56(2):511-8.
2003: Joseph M Tuscano; Robert T O'Donnell; Laird A Miers; Linda A Kroger; David L Kukis; Kathleen R Lamborn; Thomas F Tedder; Gerald L DeNardo
Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts.
Blood 2003;101(9):3641-7.
2003: Yuichi Hirose; Kenneth Aldape; Susan Chang; Kathleen R Lamborn; Mitchel S Berger; Burt Feuerstein
Grade II astrocytomas are subgrouped by chromosome aberrations.
Cancer genetics and cytogenetics 2003;142(1):1-7.
2002: David A Larson; Michael Prados; Kathleen R Lamborn; Vernon Smith; Penny K Sneed; Susan Chang; Kelly M Nicholas; William M Wara; Daniel Devriendt; Sandeep Kunwar; Mitch Berger; Michael W McDermott
Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma.
International journal of radiation oncology, biology, physics 2002;54(5):1397-404.
2002: Eric C Burton; Kathleen R Lamborn; Burt Feuerstein; Michael Prados; James Scott; Peter Forsyth; Sandra Passe; Robert B Jenkins; Kenneth Aldape
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
Cancer research 2002;62(21):6205-10.
2002: Giuseppe Zardo; Maarit Tiirikainen; Chibo Hong; Anjan Misra; Burt Feuerstein; Stanislav Volik; Colin C Collins; Kathleen R Lamborn; Andrew Bollen; Daniel Pinkel; Donna G Albertson; Joseph F Costello
Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors.
Nature genetics 2002;32(3):453-8.
2002: Philip V Theodosopoulos; Elysa Marco; Carol Applebury; Kathleen R Lamborn; Charles B Wilson
Predictive model for pain recurrence after posterior fossa surgery for trigeminal neuralgia.
Archives of neurology 2002;59(8):1297-302.
2002: Patricia A Burke; Sally J DeNardo; Laird A Miers; Kathleen R Lamborn; Siegfried Matzku; Gerald L DeNardo
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
Cancer research 2002;62(15):4263-72.
2002: Sarah S Donaldson; Melissa M Hudson; Kathleen R Lamborn; Michael P Link; Larry Kun; Amy L Billett; Karen C Marcus; Craig A Hurwitz; Jeffrey A Young; Nancy J Tarbell; Howard J Weinstein
VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(14):3081-7.
2002: Hiroko Kuriyama; Kathleen R Lamborn; Judith R O'Fallon; Nancy L Iturria; Thomas Sebo; Paul L Schaefer; Bernd W Scheithauer; Jan C Buckner; Nagato Kuriyama; Robert B Jenkins; Mark Israel
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
Neuro-oncology 2002;4(3):179-86.
2002: Jay Y Chun; Michael W McDermott; Kathleen R Lamborn; Charles B Wilson; Randall T Higashida; Mitchel S Berger
Delayed surgical resection reduces intraoperative blood loss for embolized meningiomas.
Neurosurgery 2002;50(6):1231-5; discussion 1235-7.
2002: Ralph Philip Ermoian; Constance S Furniss; Kathleen R Lamborn; Daniel Basila; Mitchel S Berger; Alexander R Gottschalk; M Kelly Nicholas; David Stokoe; Daphne A Haas-Kogan
Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1100-6.
2002: Tomoko Ozawa; Jingli Wang; Lily J Hu; Andrew W Bollen; Kathleen R Lamborn; Dennis F Deen
Growth of human glioblastomas as xenografts in the brains of athymic rats.
In vivo (Athens, Greece) 2002;16(1):55-60.
2002: Eric C Burton; Kathleen R Lamborn; Peter Forsyth; James Scott; Jason O'Campo; Jane Uyehara-Lock; Michael Prados; Mitchel Berger; Sandra Passe; Joon H Uhm; Brian P O'Neill; Robert B Jenkins; Kenneth Aldape
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):180-7.
2002: Robert T O'Donnell; Sally J DeNardo; Laird A Miers; Kathleen R Lamborn; David L Kukis; Gerald L DeNardo; Frederick J Meyers
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
The Prostate 2002;50(1):27-37.
2001: Jean Lee Nakamura; Lynn J Verhey; Vernon Smith; Paula L Petti; Kathleen R Lamborn; David A Larson; William M Wara; Michael W McDermott; Penny K Sneed
Dose conformity of gamma knife radiosurgery and risk factors for complications.
International journal of radiation oncology, biology, physics 2001;51(5):1313-9.
2001: G Evren Keles; Kathleen R Lamborn; Mitchel S Berger
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.
Journal of neurosurgery 2001;95(5):735-45.
2001: Sandeep Kunwar; G Mohapatra; Andrew Bollen; Kathleen R Lamborn; Michael Prados; Burt Feuerstein
Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival.
Cancer research 2001;61(20):7683-8.
2001: Hangjun Ruan; H Su; Lily Hu; Kathleen R Lamborn; Y W Kan; Dennis F Deen
A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy.
Neoplasia (New York, N.Y.) 2001;3(3):255-63.
2001: Karyn A Goodman; Penny K Sneed; Michael W McDermott; C Y Shiau; Kathleen R Lamborn; S Chang; E Park; William M Wara; David A Larson
Relationship between pattern of enhancement and local control of brain metastases after radiosurgery.
International journal of radiation oncology, biology, physics 2001;50(1):139-46.
2001: R Hoffman; Penny K Sneed; Michael W McDermott; S Chang; Kathleen R Lamborn; E Park; William M Wara; David A Larson
Radiosurgery for brain metastases from primary lung carcinoma.
Cancer journal (Sudbury, Mass.) 2001;7(2):121-31.
2001: Nagato Kuriyama; Hiroko Kuriyama; CM Julin; Kathleen R Lamborn; Mark Israel
Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
Cancer research 2001;61(5):1805-9.
2001: Y Hirose; Kenneth Aldape; Andrew Bollen; C D James; Daniel J Brat; Kathleen R Lamborn; M Berger; Burt Feuerstein
Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
The American journal of pathology 2001;158(3):1137-43.
2001: ML Simmons; Kathleen R Lamborn; M Takahashi; P Chen; Mark Israel; Mitchel S Berger; Tony E Godfrey; Janice M Nigro; Michael Prados; S Chang; F G Barker; Kenneth Aldape
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
Cancer research 2001;61(3):1122-8.
2001: Michael D Prados; William M Wara; Penny K Sneed; Michael McDermott; Susan M Chang; Jane Rabbitt; Margaretta Page; Mary Malec; RL Davis; Philip H Gutin; Kathleen R Lamborn; Charles B Wilson; Theodore L Phillips; David A Larson
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
International journal of radiation oncology, biology, physics 2001;49(1):71-7.
2000: Nagato Kuriyama; H Kuriyama; CM Julin; Kathleen R Lamborn; Mark Israel
Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy.
Human gene therapy 2000;11(16):2219-30.
2000: Robert T O'Donnell; Sally J DeNardo; Gerald L DeNardo; Laird A Miers; Kathleen R Lamborn; David L Kukis; Frederick J Meyers
Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice.
The Prostate 2000;44(3):187-92.
2000: Sally J DeNardo; Patricia A Burke; BR Leigh; Robert T O'Donnell; Laird A Miers; Linda A Kroger; Simon L Goodman; Siegfried Matzku; Alfred Jonczyk; Kathleen R Lamborn; Gerald L DeNardo
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy.
Cancer biotherapy & radiopharmaceuticals 2000;15(1):71-9.
2000: Edward Graves; Sarah J Nelson; Daniel B Vigneron; Cynthia Chin; Lynn J Verhey; Michael McDermott; David Larson; Penny K Sneed; Susan Chang; Michael D Prados; Kathleen R Lamborn; William P Dillon
A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.
Neurosurgery 2000;46(2):319-26; discussion 326-8.
2000: Victor Levin; Kathleen R Lamborn; William W Wara; Richard Davis; M Edwards; Jane Rabbitt; Mary Malec; Michael D Prados
Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Neuro-oncology 2000;2(1):22-8.
1999: Robert T O'Donnell; Gerald L DeNardo; David L Kukis; Kathleen R Lamborn; Sui Shen; Aina Yuan; Desiree S Goldstein; Catherine E. Carr; Gary R Mirick; Sally J DeNardo
A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2014-20.
1999: Hangjun Ruan; Jingli Wang; Lily Hu; C S Lin; Kathleen R Lamborn; Dennis F Deen
Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX.
Neoplasia (New York, N.Y.) 1999;1(5):431-7.
1999: E Tada; C Yang; Glenn T Gobbel; Kathleen R Lamborn; John R Fike
Long-term impairment of subependymal repopulation following damage by ionizing irradiation.
Experimental neurology 1999;160(1):66-77.
1999: Robert T O'Donnell; Gerald L DeNardo; David L Kukis; Kathleen R Lamborn; Sui Shen; Aina Yuan; Desiree S Goldstein; Gary R Mirick; Sally J DeNardo
67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3330s-3336s.
1999: Tomoko Ozawa; R M Lu; Lily J Hu; Kathleen R Lamborn; Michael D Prados; Dennis F Deen
Radiopotentiation of human brain tumor cells by sodium phenylacetate.
Cancer letters 1999;142(2):139-46.
1999: Gerald L DeNardo; Sally J DeNardo; Sui Shen; DA Denardo; Gary R Mirick; DJ Macey; Kathleen R Lamborn
Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(8):1317-26.
1999: C Russo; Malgorzata Pellarin; Ola Tingby; Andrew W Bollen; Kathleen R Lamborn; G Mohapatra; V Peter Collins; Burt Feuerstein
Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors.
Cancer 1999;86(2):331-9.
1999: Stephen L Huhn; G Mohapatra; Andrew Bollen; Kathleen R Lamborn; Michael D Prados; Burt Feuerstein
Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: correlation with radiation treatment outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1435-43.
1999: B Horn; Richard L Heideman; R Geyer; Ian F Pollack; Roger Packer; Joel Goldwein; T Tomita; P Schomberg; Joann Ater; L Luchtman-Jones; K Rivlin; Kathleen R Lamborn; Michael Prados; Andrew Bollen; M Berger; G Dahl; E McNeil; K Patterson; D Shaw; M Kubalik; C Russo
A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors.
Journal of pediatric hematology/oncology 1999;21(3):203-11.
1999: Kathleen R Lamborn; Michael D Prados; S B Kaplan; R L Davis
Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
Cancer 1999;85(4):925-35.
1999: Penny K Sneed; Kathleen R Lamborn; J M Forstner; Michael W McDermott; Susan Chang; E Park; Philip H Gutin; Theodore L Phillips; William M Wara; David A Larson
Radiosurgery for brain metastases: is whole brain radiotherapy necessary?
International journal of radiation oncology, biology, physics 1999;43(3):549-58.
1999: A K Metzger; G Mohapatra; YA Minn; Andrew W Bollen; Kathleen R Lamborn; F M Waldman; C B Wilson; Burt Feuerstein
Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization.
Journal of neurosurgery 1999;90(2):306-14.
1999: J Blake Tyrrell; Kathleen R Lamborn; L T Hannegan; Carol B Applebury; Charles B Wilson
Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results.
Neurosurgery 1999;44(2):254-61; discussion 261-3.
1999: Michael D Prados; Michael S Edwards; Susan M Chang; C Russo; Richard Davis; Jane Rabbitt; Margaretta Page; Kathleen R Lamborn; William M Wara
Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.
International journal of radiation oncology, biology, physics 1999;43(2):279-85.
1998: Sally J DeNardo; Carol M Richman; David L Kukis; Sui Shen; Kathleen R Lamborn; Laird A Miers; Linda A Kroger; E A Perez; Gerald L DeNardo
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol.
Anticancer research 1998;18(6A):4011-8.
1998: Gerald L DeNardo; Linda A Kroger; Claude F Meares; Carol M Richman; QA Salako; Sui Shen; Kathleen R Lamborn; James J Peterson; Laird A Miers; G R Zhong; Sally J DeNardo
Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(10):2483-90.
1998: Gerald L DeNardo; Sally J DeNardo; Desiree S Goldstein; Linda A Kroger; Kathleen R Lamborn; N B Levy; John P McGahan; QA Salako; Sui Shen; J P Lewis
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3246-56.
1998: Aviva Abosch; J Blake Tyrrell; Kathleen R Lamborn; L T Hannegan; Carol B Applebury; Charles B Wilson
Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.
The Journal of clinical endocrinology and metabolism 1998;83(10):3411-8.
1998: Gerald L DeNardo; Sally J DeNardo; Kathleen R Lamborn; D S Goldstein; N B Levy; J P Lewis; L F O'Grady; A Raventos; Linda A Kroger; DJ Macey; John P McGahan; S L Mills; Sui Shen
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody.
Cancer biotherapy & radiopharmaceuticals 1998;13(4):239-54.
1998: Tomoko Ozawa; Jingli Wang; Lily J Hu; Kathleen R Lamborn; Andrew W Bollen; Dennis F Deen
Characterization of human glioblastoma xenograft growth in athymic mice.
In vivo (Athens, Greece) 1998;12(4):369-74.
1998: MD Weil; Kathleen R Lamborn; Michael S Edwards; William M Wara
Influence of a child's sex on medulloblastoma outcome.
JAMA : the journal of the American Medical Association 1998;279(18):1474-6.
1998: Sally J DeNardo; David L Kukis; Laird A Miers; Michelle D Winthrop; Linda A Kroger; QA Salako; Sui Shen; Kathleen R Lamborn; Paul H Gumerlock; Claude F Meares; Gerald L DeNardo
Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(5):842-9.
1998: Gerald L DeNardo; Sui Shen; Sally J DeNardo; S Q Liao; Kathleen R Lamborn; DA Denardo; Aina Yuan
Quantification of iodine-131 in tumors using a threshold based on image contrast.
European journal of nuclear medicine 1998;25(5):497-502.
1998: John R Fike; Glenn T Gobbel; A H Mesiwala; H J Shin; M Nakagawa; Kathleen R Lamborn; T M Seilhan; P J Elliott
Cerebrovascular effects of the bradykinin analog RMP-7 in normal and irradiated dog brain.
Journal of neuro-oncology 1998;37(3):199-215.
1998: G Mohapatra; A W Bollen; D H Kim; Kathleen R Lamborn; D H Moore; M D Prados; Burt Feuerstein
Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade.
Genes, chromosomes & cancer 1998;21(3):195-206.
1998: Michael D Prados; Charles B Scott; Marvin Rotman; Philip Rubin; Kevin Murray; William T Sause; Sucha O Asbell; R Comis; Walter Curran; J Nelson; RL Davis; Victor Levin; Kathleen R Lamborn; Theodore L Phillips
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
International journal of radiation oncology, biology, physics 1998;40(3):653-9.
1998: Penny K Sneed; Paul R Stauffer; Michael W McDermott; Chris J Diederich; Kathleen R Lamborn; Michael D Prados; Susan Chang; K A Weaver; L Spry; Mary Malec; S A Lamb; B Voss; RL Davis; William M Wara; David A Larson; Theodore L Phillips; Philip H Gutin
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
International journal of radiation oncology, biology, physics 1998;40(2):287-95.
1998: Michael D Prados; David A Larson; Kathleen R Lamborn; Michael W McDermott; Penny K Sneed; William M Wara; Susan M Chang; E E Mack; H G Krouwer; K L Chandler; Ronald E Warnick; RL Davis; Jane Rabbitt; Mary Malec; Victor Levin; Philip H Gutin; Theodore L Phillips; Charles B Wilson
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
International journal of radiation oncology, biology, physics 1998;40(1):57-63.
1997: Gerald L DeNardo; Kathleen R Lamborn; Desiree S Goldstein; Linda A Kroger; Sally J DeNardo
Increased survival associated with radiolabeled Lym-1 therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Cancer 1997;80(12 Suppl):2706-11.
1997: Sally J DeNardo; Linda A Kroger; Kathleen R Lamborn; Laird A Miers; Robert T O'Donnell; David L Kukis; Carol M Richman; Gerald L DeNardo
Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma.
Cancer 1997;80(12 Suppl):2583-90.
1997: Gerald L DeNardo; David L Kukis; Sally J DeNardo; Sui Shen; LF Mausner; Robert T O'Donnell; Kathleen R Lamborn; Frederick J Meyers; Suresh C Srivastava; Laird A Miers
Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2.
Cancer 1997;80(12 Suppl):2576-82.
1997: Kathleen R Lamborn; G L DeNardo; S J DeNardo; D S Goldstein; Sui Shen; E C Larkin; L A Kroger
Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1253-60.
1997: Q T Le; MD Weil; William M Wara; Kathleen R Lamborn; Michael D Prados; Michael S Edwards; Philip H Gutin
Adult medulloblastoma: an analysis of survival and prognostic factors.
The cancer journal from Scientific American 1997;3(4):238-45.
1997: B J Wyrick; T Ozawa; Kathleen R Lamborn; Andrew W Bollen; Dennis F Deen
Effects of Matrigel on the SF-767 malignant glioma athymic mouse tumor model.
Anticancer research 1997;17(4A):2419-25.
1997: C Shinohara; Glenn T Gobbel; Kathleen R Lamborn; E Tada; John R Fike
Apoptosis in the subependyma of young adult rats after single and fractionated doses of X-rays.
Cancer research 1997;57(13):2694-702.
1997: Sally J DeNardo; L F O'Grady; Carol M Richman; Desiree S Goldstein; Robert T O'Donnell; DA Denardo; Linda A Kroger; Kathleen R Lamborn; Karl Erik Hellström; Ingegerd Hellström; Gerald L DeNardo
Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody.
Anticancer research 1997;17(3B):1745-51.
1997: Michael D Prados; Michael S Edwards; Jane Rabbitt; Kathleen R Lamborn; RL Davis; Victor Levin
Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.
Journal of neuro-oncology 1997;32(3):235-41.
1997: Sally J DeNardo; David L Kukis; Linda A Kroger; Robert T O'Donnell; Kathleen R Lamborn; Laird A Miers; DG DeNardo; Claude F Meares; Gerald L DeNardo
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(8):4000-4.
1997: C Y Shiau; Penny K Sneed; Hui-Kuo G Shu; Kathleen R Lamborn; Michael W McDermott; Susan Chang; P Nowak; Paula L Petti; Vernon Smith; Lynn J Verhey; M Ho; E Park; William M Wara; Philip H Gutin; David A Larson
Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control.
International journal of radiation oncology, biology, physics 1997;37(2):375-83.
1997: Sui Shen; Gerald L DeNardo; Sally J DeNardo; Aina Yuan; DA Denardo; Kathleen R Lamborn
Reproducibility of operator processing for radiation dosimetry.
Nuclear medicine and biology 1997;24(1):77-83.
1996: David A Larson; Philip H Gutin; M McDermott; Kathleen R Lamborn; Penny K Sneed; W M Wara; John C Flickinger; Douglas Kondziolka; L Dade Lunsford; W R Hudgins; G M Friehs; K Haselsberger; KA Leber; G Pendl; S S Chung; R J Coffey; Robert P Dinapoli; E G Shaw; S Vermeulen; R F Young; Masafumi Hirato; H K Inoue; C Ohye; T Shibazaki
Gamma knife for glioma: selection factors and survival.
International journal of radiation oncology, biology, physics 1996;36(5):1045-53.
1996: DA Denardo; Gerald L DeNardo; Aina Yuan; Sui Shen; Sally J DeNardo; D J Macey; Kathleen R Lamborn; M Mahe; M W Groch; W D Erwin
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(12):1970-5.
1996: Hui-Kuo G Shu; Penny K Sneed; C Y Shiau; Michael W McDermott; Kathleen R Lamborn; E Park; M Ho; Paula L Petti; Vernon Smith; Lynn J Verhey; W M Wara; Philip H Gutin; David A Larson
Factors influencing survival after gamma knife radiosurgery for patients with single and multiple brain metastases.
The cancer journal from Scientific American 1996;2(6):335-42.
1996: Michael D Prados; W Wara; Michael S Edwards; Joann Ater; J Rabbit; Kathleen R Lamborn; R Davis; Victor Levin
Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Pediatric neurosurgery 1996;25(4):174-81.
1996: M Nakagawa; M Bellinzona; T M Seilhan; Glenn T Gobbel; Kathleen R Lamborn; John R Fike
Microglial responses after focal radiation-induced injury are affected by alpha-difluoromethylornithine.
International journal of radiation oncology, biology, physics 1996;36(1):113-23.
1996: Penny K Sneed; C Russo; C O Scharfen; Michael D Prados; Mary Malec; David A Larson; Kathleen R Lamborn; S A Lamb; B Voss; K A Weaver; Theodore L Phillips; Philip H Gutin; W M Wara; Michael S Edwards
Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors.
Pediatric neurosurgery 1996;24(6):314-22.
1996: N Gupta; Kathleen R Lamborn; Dennis F Deen
A statistical approach for analyzing clonogenic survival data.
Radiation research 1996;145(5):636-40.
1996: Penny K Sneed; Kathleen R Lamborn; David A Larson; Michael D Prados; Mary Malec; Michael W McDermott; K A Weaver; Theodore L Phillips; W M Wara; Philip H Gutin
Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme.
International journal of radiation oncology, biology, physics 1996;35(1):37-44.
1996: F G Barker; Michael D Prados; Susan M Chang; Philip H Gutin; Kathleen R Lamborn; David A Larson; Mary Malec; Michael W McDermott; Penny K Sneed; W M Wara; Charles B Wilson
Radiation response and survival time in patients with glioblastoma multiforme.
Journal of neurosurgery 1996;84(3):442-8.
1996: F G Barker; Michael D Prados; Susan M Chang; RL Davis; Philip H Gutin; Kathleen R Lamborn; David A Larson; Michael W McDermott; Penny K Sneed; Charles B Wilson
Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.
International journal of radiation oncology, biology, physics 1996;34(4):803-8.
1996: J Wang; W Hyun; Kathleen R Lamborn; Dennis F Deen
Measurement of radiation-induced damage in human glioma cells with flow cytometry.
Cancer research 1996;56(1):154-7.
1995: Gerald L DeNardo; Kathleen R Lamborn; Sally J DeNardo; Desiree S Goldstein; E G Dolber-Smith; Linda A Kroger; E C Larkin; Sui Shen
Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.
Cancer research 1995;55(23 Suppl):5893s-5898s.
1995: Sally J DeNardo; Paul H Gumerlock; Michelle D Winthrop; Philip C Mack; S G Chi; Kathleen R Lamborn; Sui Shen; Laird A Miers; Ralph W deVere White; Gerald L DeNardo
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.
Cancer research 1995;55(23 Suppl):5837s-5841s.
1995: Michael D Prados; R E Warnick; W M Wara; David A Larson; Kathleen R Lamborn; Charles B Wilson
Medulloblastoma in adults.
International journal of radiation oncology, biology, physics 1995;32(4):1145-52.
1995: Penny K Sneed; Michael D Prados; Michael W McDermott; David A Larson; Mary Malec; Kathleen R Lamborn; RL Davis; K A Weaver; W M Wara; Theodore L Phillips
Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost.
Neurosurgery 1995;36(5):898-903; discussion 903-4.
1995: Michael D Prados; W M Wara; Michael S Edwards; David A Larson; Kathleen R Lamborn; Victor Levin
The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy.
International journal of radiation oncology, biology, physics 1995;32(1):85-91.
1995: G L De Nardo; Linda A Kroger; Gary R Mirick; Kathleen R Lamborn; S J De Nardo
Analysis of antiglobulin (HAMA) response in a group of patients with B-lymphocytic malignancies treated with 131I-Lym-1.
The International journal of biological markers 1995;10(2):67-74.
1994: Sally J DeNardo; Gary R Mirick; Linda A Kroger; L F O'Grady; Kent L Erickson; Aina Yuan; Kathleen R Lamborn; I Hellstrom; K E Hellstrom; Gerald L DeNardo
The biologic window for chimeric L6 radioimmunotherapy.
Cancer 1994;73(3 Suppl):1023-32.
1994: S Ito; K L Chandler; Michael D Prados; Kathleen R Lamborn; J Wynne; Mary Malec; Charles B Wilson; RL Davis; T Hoshino
Proliferative potential and prognostic evaluation of low-grade astrocytomas.
Journal of neuro-oncology 1994;19(1):1-9.
1994: Gerald L DeNardo; Kathleen R Lamborn; Sally J DeNardo; Linda A Kroger
Use of response surface statistical designs to detect effects of biologic response modifiers such as IL-2.
Biotechnology therapeutics 1994;5(1-2):15-26.
1992: Michael D Prados; Philip H Gutin; Theodore L Phillips; W M Wara; David A Larson; Penny K Sneed; RL Davis; D K Ahn; Kathleen R Lamborn; Charles B Wilson
Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989.
International journal of radiation oncology, biology, physics 1992;23(1):3-8.
1992: C O Scharfen; Penny K Sneed; W M Wara; David A Larson; Theodore L Phillips; Michael D Prados; K A Weaver; Mary Malec; P Acord; Kathleen R Lamborn
High activity iodine-125 interstitial implant for gliomas.
International journal of radiation oncology, biology, physics 1992;24(4):583-91.
1991: Glenn T Gobbel; L J Marton; Kathleen R Lamborn; T M Seilhan; John R Fike
Modification of radiation-induced brain injury by alpha-difluoromethylornithine.
Radiation research 1991;128(3):306-15.
1991: Sally J DeNardo; L F O'Grady; D J Macey; Linda A Kroger; Gerald L DeNardo; Kathleen R Lamborn; N B Levy; S L Mills; I Hellstrom; K E Hellstrom
Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(6):621-31.